Rainbow Childrens Medicare Sees Notable Revision in Its Stock Evaluation by MarketsMOJO
Rainbow Childrens Medicare has recently undergone a revision in its score by MarketsMojo, reflecting a positive change in its overall evaluation. The company has shown strong management efficiency and a solid ability to handle debt, alongside impressive growth in operating profit. With high institutional holdings and a notable return over the past year, the stock remains a focal point for investors.
Rainbow Childrens Medicare, a prominent player in the Hospital & Healthcare Services sector, has recently experienced a noteworthy adjustment in its evaluation by MarketsMOJO. The stock has been added to MarketsMOJO's list, reflecting a positive shift in its overall assessment.The company has demonstrated impressive management efficiency, highlighted by a robust return on capital employed (ROCE) of 20.05%. Additionally, Rainbow Childrens Medicare showcases a strong capacity to manage its debt, evidenced by a low debt-to-EBITDA ratio of 1.18 times. This financial stability is further underscored by the company's healthy long-term growth trajectory, with operating profit increasing at an annual rate of 28.61%.
Recent financial results have also been promising, with net sales reaching a record high of Rs 417.46 crore in September 2024, following two consecutive quarters of negative performance. The stock's technical indicators have shifted positively, moving from a mildly bullish stance to a more favorable outlook.
With high institutional holdings at 38.95%, Rainbow Childrens Medicare continues to attract attention for its market-beating performance, generating a return of 25.79% over the past year, significantly outpacing the broader market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
